Obtaining and Storing Wound Debridment Samples For Immediate or Future Wound-Related Scientific Study
NCT ID: NCT00759499
Last Updated: 2020-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
829 participants
OBSERVATIONAL
2007-01-31
2021-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obtaining and Storing Blood Samples and Debridement Samples for Wound Related Research
NCT00762697
Pilot Study Comparing Talidermâ„¢ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds
NCT00686296
Investigating the Benefits of a 3D Camera for Recording Healing Wound Dimensions
NCT03355599
Accurate AI-based Characterisation of Surface Size, Depth and Tissue Composition in Hard-to-Heal Wounds
NCT07211295
Feasibility Study of a Novel Device for Chronic Wounds
NCT00660049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. The subject must have a full thickness wound.
2. The subject must be a candidate for sharp debridement.
3. The subject must be 18 years of age or older
4. The subject must be mentally competent as determined by the Principal Investigator.
Exclusion Criteria
1\. The subject may not be currently incarcerated or pregnant.
* Nursing home and hospitalized subjects will not be excluded from this study because these subjects represent a large part of the wounded population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Debridement
The intent of this protocol is to salvage wound material that is normally destined for destruction, so it can be used in wound-related scientific studies. This clinical wound material can be studied in order to better understand the molecular, cellular, or ecological components of the wound system. These studies may be able to provide important insights into the keys of wound healing, wound persistence, or wound deterioration.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject must be a candidate for sharp debridement.
* The subject must be 18 years of age or older
* The subject must be mentally competent as determined by the Principal Investigator
Exclusion Criteria
* Nursing home and hospitalized subjects will not be excluded from this study because these subjects represent a large part of the wounded population.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southwest Regional Wound Care Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randall Wolcott
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Randall D Wolcott, M.D.
Role: PRINCIPAL_INVESTIGATOR
Southwest Regional Wound Care Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Soutwest Regional Wound Care Center
Lubbock, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
56-RW-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.